Market Research Blog – Page 9701 – New Product Development

Biotherapeutics Virus removal filters Market is anticipated to be valued at US$ 424.3 Million in 2022 | FMI

[290 Pages Report] The increasing investment by the government is the major role for better healthcare is expected to drive the market. The companies are engrossed in introducing the products for combat dressing. The biotherapeutics virus removal filters market is classified by technology, application and end user. In terms of technology, the global market of biotherapeutics virus removal filters is divided into size exclusion technology and depth filtration technology. By application the biotherapeutics virus removal filters market is segmented as monoclonal antibodies, blood & plasma, enzymes and protein. By end user, the biotherapeutics virus removal filters market is segmented into biopharmaceutical companies, clinical research organizations, academic institutes and others. Among all end user, biopharmaceutical companies are expected to gain maximum value share over the forecast period.

Biotherapeutics Virus removal filters Market Overview

The biotherapeutics virus removal filters provide robust and economic solutions to stop the potential viral contaminants in a sample from the desired product. By using virus removal technique, all the non-enveloped viruses can be completely removed from the sample. The biotherapeutics virus removal filters are basically used during the manufacturing of biotherapeutic drug products or samples such as therapeutic replacement enzymes, antibodies, blood, derivatives of plasma and biopharmaceuticals.

The biotherapeutics virus removal filters can be used either in vivo or in- vitro environment. In biotherapeutics virus removal filtration, the virus removability is based on size-exclusion mechanism that is those viruses which are superior to the mean pore size, they became trapped.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6054

Biotherapeutics Virus removal filters Market: Drivers and Restrains

The global biotherapeutics virus removal filters market is anticipated to register a significant CAGR over a forecast period. The pre-determined risk of contamination in biotherapeutic products is the major factor that can upsurge the growth of the biotherapeutics virus removal filters market.

The global market of biotherapeutics virus removal filters market is driven by the increasing investments in research sector by government. The lack of experience and less awareness can be the factors which can hamper the growth of the market of biotherapeutics virus removal filters.

Biotherapeutics Virus removal filters Market: Regional overview

On the basis of geography, biotherapeutics virus removal filters market is segmented as North America, Latin America, Western Europe, Eastern Europe, Japan, Asia-Pacific and Middle East & Africa. North America is expected to dominate the biotherapeutics virus removal filters market due to the advent of advanced technologies in this region.

Europe is also contributing the moderate shares to the market due to the advanced medical facilities and easy availability of the biotherapeutics virus removal filters in the market. APAC is the most lucrative market for the biotherapeutics virus removal filters due to increasing research facilities and developing biopharmaceutical industry in the region is expected to show a robust growth to the global biotherapeutics virus removal filters market.

MEA is at a nascent stage to the global biotherapeutics virus removal filters market and anticipated to register a decent growth to the market over a forecast period. Overall, the global biotherapeutics virus removal filters market is expected to show significant growth over a forecast period.

Biotherapeutics Virus removal filters Market: Key Players

Some of the major players in the market are Pall Corporation, Z-Medica, LLC, Asahi Kasei Corporation, Merck KGaA, Sartorius AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6054

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Biotherapeutics Virus removal filters Market: Segmentation

The biotherapeutics virus removal filters market is classified into technology, application and end users.

Biotherapeutics Virus removal filters Market is segmented, by Technology –

Size Exclusion Technology
Depth Filtration Technology

Biotherapeutics Virus removal filters Market is segmented, by Application –

Monoclonal Antibodies
Blood & Plasma
Enzymes
Proteins

Biotherapeutics Virus removal filters Market segmented, by End User-

Biopharmaceutical Companies
Clinical Research Organizations
Academic Institutes
Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6054

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Direct-to-Consumer Genetic Testing Market is expected to grow at a CAGR of 11.2% from 2022 to 2032

[300 Pages Report] As per Future Market Insights’ latest study, the global direct-to-consumer genetic testing market stood at around US$ 1.3 Bn in 2021 and is projected to exhibit a CAGR of 11.2% over the forecast period, with an estimated valuation of US$ 4.0 Bn in 2032.

The direct-to-consumer genetic testing market is expected to grow at a steady pace due to increasing demand for personalized medicines in healthcare facilities for personal use, as well as safety of patients’ health. Emergence of various epidemics and their looming health dangers is also projected to boost the demand for direct-to-consumer genetic testing solutions among the general public and healthcare professionals, thereby supporting the market.

Direct-to-Consumer Genetic Testing Market Estimated Size (2022E)	US$ 1.4 Bn
Projected Market Valuation (2032F)	US$ 4.0 Bn
Value-based CAGR (2022-2032)	11.2%
Collective Value Share: Top 5 Countries (2022E)	56.4%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15137

Furthermore, ongoing in terms of characterization of DNA sequence variants related to the risk of commonly diagnosed diseases such as Crohn’s disease, type-2 diabetes, breast cancer, MI, and prostate cancer are set to aid growth. Despite significant attempts by dedicated researchers, only a few sequence variants associated with these diseases had been appropriately verified by replication in well-powered studies before 2006.

In addition, development of cutting-edge microarray genetic analysis technologies is expected to enable researchers to determine genotypes at hundreds and thousands of single-nucleotide polymorphisms (SNPs) instantaneously and cost-effectively across the genome. Additionally, key players are focusing on novel product developments with enhanced efficacy in terms of efficiency and safety.

For instance, in August 2020, Ancestry, a global leader in family history and consumer genomics, announced the launch of AncestryHealth. It is powered by next generation sequencing (NGS), which would help in providing easy access to important information about wellbeing to consumers.

Key Takeaways: Direct-To-Consumer Genetic Testing Market

By product, the ancestry tests segment is projected to held approximately 8% of the direct-to-consumer genetic testing market share in 2021.
Based on technology, the single nucleotide polymorphism chips segment generated a market share of around 5% in 2021.
In terms of sample, the saliva category held approximately 3% of the direct-to-consumer genetic testing market share in 2021.
The U.S. direct-to-consumer genetic testing market remained at the forefront in 2021 by generating a share of 1%.
In Asia Pacific, China direct-to-consumer genetic testing market is anticipated to exhibit steady growth at a CAGR of 5% in the forthcoming years.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15137

“Rising initiatives to promote health & well-being and introduction of microarray genetic analysis platforms are set to propel the direct-to-consumer genetic testing market across the globe,” says an analyst of Future Market Insights.

Market Competition

The direct-to-consumer genetic testing market is fragmented with the presence of various local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce novel direct-to-consumer genetic testing kits with enhanced efficacy.

In October 2021, 23andMe, Inc. signed a merger agreement with Lemonaid Health, Inc. The acquisition would provide customers with telemedicine facilities for the assessment of their medical health and other related services online.

More Valuable Insights on Direct-To-Consumer Genetic Testing Market

Future Market Insights offers a unique perspective and actionable insights on the direct-to-consumer genetic testing market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product (pharmacogenetics tests, carrier screening tests, genetic health risk (GHR) tests, cancer predisposition tests, low-risk general wellness tests, and ancestry tests), technology (single nucleotide polymorphism chip and whole-genome sequencing), sample (saliva, blood, and urine), sales channel (institutional sales (hospitals, specialty clinics, diagnostic laboratories, and others) and retail sales (retail pharmacies and online sales)) across seven key regions of the world.

Key Players :

23andMe
Ancestry DNA
Color Genomics, Inc.
Genetic Technology (EasyDNA)
Full Genomes Corporation, Inc.
Helix OpCo LLC
IDENTIGENE, LLC/ DNA Diagnostics Center
Living DNA Ltd
MyHeritage Ltd
Prenetics Limited
Family Tree DNA
Interleukin Genetics/orig3n
Counsyl/Myriad Genetics, Inc.
Veritas Genetics
Fulgent Genomics

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15137

Direct-to-Consumer Genetic Testing Market Outlook by Category

By Product:

Pharmacogenetics Tests
Carrier Screening Tests
Genetic Health Risk (GHR) Tests
Cancer Predisposition Tests
Low-Risk General Wellness Tests
Ancestry Tests

By Technology:

Single Nucleotide Polymorphism Chip
Whole Genome Sequencing

By Sample:

Saliva
Urine
Blood

By Sales Channel:

Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
Retail Sales
- Retail Pharmacies
- Online Sales

About FMI:

Steroid-Free Nasal Sprays Market is projected to reach US$ 14.9 Billion by 2032 | FMI

[225 Pages Report] Steroid-free nasal sprays are medications that are directly delivered to nasal cavities with the avoidance of first-pass metabolism and also provide better bioavailability. It includes nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, and nasal cromolyn sodium sprays.

As per Future Market Insights’ latest industry analysis, the global steroid-free nasal sprays market was valued at over US$ 7.75 Bn in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period, pushing the market size to US$ 14.9 Bn by 2032.

Data Points	Market Insights
Steroid-free Nasal Sprays Market Base Yea Value (2021)	US$ 7.7 Bn
Estimated Market Size (2022)	US$ 8.1 Bn
Projected Market Valuation (2032)	US$ 14.9 Bn
Value-based CAGR (2022-2032)	6.3%
Share of Top 5 Countries	57.9%

There is a subsequent rise in the prevalence of allergic rhinitis worldwide due to several risk factors including urbanization and environmental pollutants. According to a recent study conducted in 2022, allergic rhinitis affects about 25% to 40% of the population worldwide. It also states that approximately 80% of allergic rhinitis symptoms develop before the age of 20.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15127

Recently, there has been an increasing emphasis on mental illnesses due to the significant rise in cases of major depressive disorders. Among these, depression is a common mental disorder. According to WHO, approximately 280 million people of all ages suffer from depression.

Due to rising adverse effects of depression, manufacturers in the steroid-free nasal sprays market are focusing on introducing products that can be used for the treatment of these disorders in the most effective manner.

Moreover, an increased number of regulatory approvals have been observed in the steroid-free nasal sprays market which is propelling the launch of innovative products. Therefore, manufacturers in the market are focusing on getting regulatory approvals to improve sales in the market.

“Rising availability of generic nasal sprays, along with increasing promotional activities by manufacturers at online channels will boost sales of steroid-free nasal sprays over the assessment period,” says an FMI analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15127

Key Takeaways:

Based on product type, sales of nasal antihistamine sprays will increase at a 5.9% CAGR through 2032.
The aqueous by formulation segment dominated the steroid-free nasal sprays market with around 4% share in 2021.
In terms of distribution channels, demand in the institutional segment will grow at a 6% CAGR through 2032.
North America accounted for the highest share of 6% of the global steroid-free nasal sprays market share in 2021.

Competition Landscape

Prominent players operating in the global steroid-free nasal sprays market are focusing on the development, launch, and approval of innovative products to improve their product portfolios. For instance:

In February 2022, Glenmark Pharmaceuticals Limited along with SaNOtize Research & Development Corp. announced the launch of FabiSpray, the nitric oxide nasal spray for the treatment of COVID-19 in India.
In March 2021, Cipla Limited announced that it has received final approval from the FDA for its abbreviated new drug application (ANDA) for Sumatriptan Nasal Spray, 20 mg which is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex nasal spray.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the steroid-free nasal sprays market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032. The global steroid-free nasal sprays market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The steroid-free nasal sprays market is segmented into three parts based on the product (nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, nasal cromolyn sodium sprays, and others), formulation (aqueous, suspension, nonaqueous-based solution, hydroalcoholic, emulsions, and dry powder/micro particles) and distribution channel- (institutional sales {hospitals, specialty clinics, community clinics, public health agencies, and others}, retail sales {retail pharmacy, drug stores, mail order pharmacy}), across seven key regions of the world.

Key Players :

Janssen Pharmaceutical, Inc.
Astra Zeneca Plc.
Cipla Ltd.
Glenmark Pharmaceuticals
Glaxosmithkline Plc.
Novartis International AG
Procter & Gamble
Sanofi S.A. (Sanofi-aventis LLC.)
Boehringer Ingelheim GmbH
AdvaCare Pharma
Bayer AG (Bayer Consumer Health
Covis Pharma S.a.r.l.
Nipro Corporation (NIPRO JMI Pharma Ltd.)
Viatris Inc. (Meda Pharmaceuticals Inc.)
Perrigo Company plc
AptarGroup, Inc.
Berry Global, Inc.
URSATEC GmbH
Gerresheimer AG
Avantor, VWR International, LLC
Spectrum Laboratory Products, Inc. (Spectrum Pharmacy Products)
SKS Bottle & Packaging, Inc.
Coster Tecnologie Speciali S.p.A

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15127

Steroid-Free Nasal Sprays Market by Category

By Product:

Nasal Antihistamine Sprays
Nasal Decongestant Sprays
Nasal Anticholinergic Sprays
Nasal Cromolyn Sodium Sprays
Others

By Formulation:

Aqueous
Suspension
Nonaqueous-Based Solution
Hydroalcoholic
Emulsions
Dry Powder/Micro Particles

By Distribution Channel:

Institutional Sales
- Hospitals
- Specialty Clinics
- Community Clinics
- Public Health Agencies
- Others
Retail Sales
- Retail Pharmacy
- Drug Stores
- Mail Order Pharmacy

About FMI:

Medical Penlights Market is projected to amass a revenue of around US$ 362.1 billion by 2032

[342 Pages Report] Medical penlights are preferred over flashlights in all the medical settings due to the professional look and more visual clarity than flashlights. Medical penlights are the used by doctors, nurses and emergency medical technicians for a general examination of mouth, ear, eyes etc.

Medical penlights are preferred by medical professionals due to a compact size and they are easy to fit into pocket or clip board. Medical penlights are mainly used for pupil test. The most common test performed using medical penlights is consensual constriction test –a test used to check reflex and brain function. Medical penlights are either disposable or reusable.

Reusable medical penlights are preferred over disposable medical penlights as they have long battery life and low lumen focus. Based on the light source, medical penlights can be classified as LED lights and medical penlights with an incandescent bulb. Disposable LED medical penlights are generally used by emergency medical technicians who have different needs in penlight.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5043

LED medical penlights are brighter than penlights with an incandescent bulb. Emergency medical technicians prefer disposable medical penlight as they do not require to carry extra batteries. New features in medical penlights such as integrated pupil gauge and stylus make it more attractive to medical professionals as these medical penlights allow professionals to check on patients and immediately update their record.

Some of the leading brands in medical penlights market include Thrunite TI4T, BOVIE FLUORO-DOT, Welch Allyn Professional Penlight, Stylus, Dixie EMS Disposable Penlight, Escolite, etc. among others.

Medical Penlights Market: Drivers and Restraints

The market for medical penlights is ever growing as medical penlights are essential in every clinic or medical settings which provide primary healthcare. However, technological advances in medical penlights such as UV medical penlights for use in minor surgical procedures, LED medical pens, etc. are expected to fuel the growth of global medical penlights market.

Medical penlights with metal light beams such as cobalt light, halogen lights etc. Availability of special pediatric medical penlights further increases the demand for medical penlights across the globe. However, alternatives for pupil test such as visual screeners are expected to deter the demand for medical penlights over the forecast period.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-5043

Medical Penlights Market: Overview

Availability of durable medical penlights for hospitals and clinic settings and disposable penlights for emergency medical technicians is attributed to continuous and steady consumption of these products in the global market.

Among both LED and incandescent bulb medical penlights, incandescent medical penlights are preferred and expected to dominate the global market as they provide better tissue color rendition which could be important to doctors and nurses. Among all end users of medical penlights, clinics segment is expected to dominate due to the high density of primary care services provided by them.

Medical Penlights Market: Regional Outlook

Geographically, global medical penlights market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global medical penlights market due to a high number of hospitals and independent medical practitioners. Western Europe is expected to be the second largest market medical penlights.

Asia Pacific market is expected to experience the highest growth rate in terms of volume due to numerous local suppliers from China and Japan.

Medical Penlights Market: Key Players

Some of the players identified in global medical penlights market include ThruNite, Bovie Medical Corporation, Welch Allyn Inc., Streamlight Inc., Dixie USA EMS Supply Company, Beaver Visitec International, American Diagnostic Corporation, GF HEALTH PRODUCTS, INC., BV Medical, Medline Industries Inc., Rudolf Riester GmbH, Essilor etc. among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5043

Key Segments Profiled in the Medical Penlights Market Survey

By Method:

LED Medical Penlights
Medical Penlights with incandescent bulb

By Light Output:

White Light
Blue Light
Red Light
Green Light
UV Light

By Usage:

Disposable Medical Penlights
Reusable Medical Penlights

By End Use:

Hospitals
Clinics
Diagnostic Centers
Emergency Medical Camps
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific
Japan
The Middle East and Africa

About FMI:

Medical Germicidal Lamps Market is expected to be US$ 560.5 Million by 2032

Medical germicidal lamp is a medical device used to visualize low contrast objects and small cavities within the body. This is used by surgeons in dental surgery, optical surgery, neuro surgery, endoscopic surgery. Medical germicidal lamps provide higher intensity and bright light, which is optimally shadow free, and can be used for viewing the body cavities during surgery. Germicidal lamps use ultraviolet light which is used for sterilization and disinfection without the use of chemicals. Medical germicidal lamps are often used to keep the disease under control so it doesn’t spread in the medical field.

These medical germicidal lamps have strong effect of ultraviolet energy which is good for sanitizing the air and killing germs & bacteria. With the help of medical germicidal lamps, fungi, moulds, mildews and many kinds of viruses can be killed. Medical germicidal lamps are used in hospitals for sterilizing surgical instruments as well as air in the operation theatre. Medical germicidal lamps use UV light, which is a short wave ultraviolet light, decapitate the bacteria, protozoa, virus and DNA base pairing.

There are three types of medical germicidal lamps namely low pressure lamps, high pressure lamps and LEDs. Low pressure lamps are similar to florescent lamps and are the most common medical germicidal lamps which provide excellent efficiency coupled with low power consumption. High pressure lamps are similar to HID lamps which radiate broad band ultraviolet radiation. High pressure lamps provide very bright white light. LEDs are the ultraviolet-C LED which use semiconductor material that produce light in a solid state device.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5030

Medical Germicidal Lamps Market: Drivers and Restraints

Medical germicidal lamps market is driven by the rise in number of surgeries and increasing demand for better healthcare facilities. Technological advancements have transformed the global medical germicidal lamps over the year and will continue to do so due to high demand of these lamps in surgery and invasive procedures. Medical germicidal lamp market is expected to grow due to enhancement of its new technology under controlled conditions. Manufacturers are more focused on top R&D facilities for further improvement and accuracy in working on new product development in developed nations. High cost of CFL and LED lamps and economic slowdown in the some of the developing economies is more likely to inhibit the growth of the medical germicidal lamp market.

Medical Germicidal Lamps Market: Key Players

Some of the key players in the medical germicidal lamps market are Steril-Aire, Spectronics Corporation, Herolab GmbH, UVP, LLC, American Ultraviolet, Light Sources, Inc., Atlantic Ultraviolet Corporation, Sankyo Denki Co.,

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness indices. The report also maps the qualitative impact of various market factors on market segments in respective geographies.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5030

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)

Medical Germicidal Lamps Market: Segmentation

Tentatively, global Medical Germicidal Lamps Market has been segmented on the basis of end user, and geography.

Based on technology, global medical germicidal lamps market is segmented as below:

LED surgical lamps
CFL surgical lamps
Halogen surgical lamps

Based on product type, global medical germicidal lamps market is segmented as below:

Ceiling mount surgical lamp
Surgical headlight lamp
Dental light lamp
Laser light
Others

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5030

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

About FMI:

Medical Drones Market is likely to cross US$ 3.06 Bn by the end of 2032 | FMI

[342 Pages Report] Medical drones are the advanced version of unmanned aerial vehicles used for delivering medical necessity in the catastrophic or emergence areas from the medical facilities. Medical drones are in research and development phase and require new technological improvement to deliver packages efficiently with minimal time. With the increasing penetration of logistic services and retailer services, will also have a positive impact on medical drones market. Various established companies such as Google, Inc. and Amazon.com, Inc. are also involving in the medical drones market.

Medical drones are aerodynamic pods used for transporting medical supplies such as drugs, vaccines, and medical aids. Medical drones are developed for rapid and safe delivery of medical supplies in the remote or inaccessible areas and war torn areas from medical facilities. With the advancement in technology and cost cutting of medical drones have led to augmented adoption mainly by military and hospitals sectors.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5109

Medical drones are in continuous research and development phase for producing a novel product with high speed, and accuracy in delivery. Medial drones are operated manually or can be programmed to fly precise route, and are advantageous as they require no landing space and can drop packages from the lower fly. The ability of medical drones to fly over closed areas and without a crew is the reason for its high demand.

Medical Drones Market: Drivers and Restraints

The growth of global medical drones market is generally driven by low cost of equipment and increasing research and development investment by government bodies are driving the growth of medical drones market. In addition, increasing penetration of medical drones in an emergency or catastrophic areas are boosting the market growth of medical drones.For instance, medical drones were adopted for delivering tele-medical packages to victims of mass casualty event held in Mississippi, U.S. However, product approval regulation have hindered commercialization of medical drones as they are not allowed to fly freely or without permission are hampering the growth of medical drones market. In addition, medical drones create risks including potential hazards and operation issues are other obstacles to the growth of medical drones market.Medical Drones Market: Region Wise Outlook

Geographically, medical drones market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. The market in North America is anticipated to hold the largest share of medical drones in the global market, followed by Western Europe, owing to the presence of increasing research and development funding from the government and private bodies. In addition, the presence of formal rules and regulation applied by federal government and presence of highly sophisticated environment are also gardening the growth of medical drones market.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-5109

The medical drones market in Asia- Pacific region and Japan are anticipated to grow at a higher rate owing to the improving healthcare facilities and increasing awareness about the benefits of medical drones in the catastrophic environment. However, the market for medical drones in regions such as Latin America, Eastern Europe, and Middle East and Africa are estimated to show a steady growth over the forecast period owing to the presence of highly fragmented distributors and scarcity of skilled professionals.

Medical Drones Market: Key Players

Some of the market participants in the global medical drones market are Zipline Inc., Flirtey, and Matternet.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends and Issues and Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Rest Of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5109

Medical Drones Market: Segmentation

On the basis of application, global medical drones market can be segmented as:

Acute Care
Vaccination Programs
Blood bank Transferring
Drug/Pharmaceutical Transferring

On the basis of end-user, global medical drones market can be segmented as:

Government Organizations
Emergency Medical Services
Blood Banks

On the basis of region, global medical drones market can be segmented as:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Middle East and Africa

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Transradial Closure Devices Market: Global sales of transradial closure devices are set to enjoy a market valuation of US$ 225.4 Mn in 2022, and further progress at a high CAGR of 6.8% to reach US$ 381.4 Mn through 2030

Mammalian Transient Protein Expression Market: The global mammalian transient protein expression market is set to enjoy a valuation of approximately US$ 641.0 Mn in 2022, and further expand at a CAGR of 9.0% to reach a valuation of US$ 1.3 Bn by the year 2030

In Vitro Fertilization Banking Services Market: Expanding at a CAGR of 10.8%, the global in vitro Fertilization banking services market is projected to increase from a valuation of US$ 3.5 Bn in 2021 to US$ 8.8 Bn by 2032

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
For Read Report: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Robotic Biopsy Devices Market is expected to register 9.4% CAGR from 2022 – 2032

[250 Pages Report] As per Future Market Insights’ latest industry analysis, the global robotic biopsy devices market was valued at around US$ 386.4 Mn in 2021 and is projected to exhibit a CAGR of 9.4% over the forecast period. The market is set to reach US$ 1.1 Bn in 2032.

One of the most significant cutting-edge technologies in neurosurgery is robot-assisted biopsy for brain tumors. Robot-assisted biopsy is used to increase the safety and effectiveness of biopsy technique, which is highly desired when organizing the management of tumor pathology.

Attributes	Key Statistics
Global Robotic Biopsy Devices Market Estimated Size (2022)	US$ 435.6 Mn
Projected Market Valuation (2032)	US$ 1.1 Bn
Value-based CAGR 2022-2032	9.4%
Collective Value Share: Top 5 Countries	50.5%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15412

The main objective of this cutting-edge technology is to add safety equipment to the modern neurosurgery operative inventory so that it can methodically improve the precision and accuracy in operation theaters, which is not otherwise conceivable. Additionally, robotic biopsy makes the thorough preoperative process easier than other types.

The market for robotic biopsy devices is anticipated to grow at a fast pace over the projected years due to rising need for safe and effective minimally invasive procedures and growing use of automated systems in the healthcare sector. It can be further attributed to rapid transformation of conventional healthcare systems to integrated digital technology.

Key Takeaways: Robotic Biopsy Devices Market

By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
By application, the brain biopsy category is leading the global robotic biopsy devices market and is projected to exhibit a CAGR of 3% during the forecast period.
By end user, hospitals held around 5% of the global robotic biopsy devices market share in 2021.
The U.S. currently dominates the North America robotic biopsy devices market and it had generated a share of about 8% in 2021.
The U.K. is set to hold a share of nearly 2% in the global robotic biopsy devices market during the assessment period.

“Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of robotic biopsy devices,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15412

Competition Landscape: Robotic Biopsy Devices Market

The market for robotic biopsy devices is oligopolistic, with the presence of a few established manufacturers. Product range of every player in the market varies as per the competitors’ licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.

In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.

What Does the Robotic Biopsy Devices Market Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the robotic biopsy devices market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product (systems and instrument & accessories), application (lung biopsy, brain biopsy, prostate biopsy, and others), and end user (hospitals, ambulatory surgical centers, and academic & research institutes) across seven key regions of the world.

Key Players :

Medtronic
Renishaw plc
iSYS Medizintechnik GmbH
Mazor Robotics
Biobot Surgical Pte Ltd
Medrobotics
Medtech SA

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15412

Robotic Biopsy Devices Market Outlook by Category

By Product:

Systems
Instrument & Accessories

By Application:

Brain Biopsy
Lung Biopsy
Prostate biopsy
Others

By End User:

Hospitals
Ambulatory Surgical Centers
Academic & Research Institutes

About FMI:

Neuro Immunoassay Market is projected to be valued at US$ 5553.2 Mn by 2032

Immunoassay is a bioanalytical method in which a quantitative analysis depends on the interaction of antigen and antibody. Neuro Immunoassay is a technique that is a quick and accurate test that can be used in laboratory and on-site to detect specific molecules. Immunoassays are the procedure that rely on the procedure of an antibody to bind to a specific structure of a molecule.

Antibodies in this are proteins that are generated by animals in response to the invasion of the antigen produced. It function on the antigen-antibody interaction procedure. Antibodies are found in blood and tissue fluids and will bind to the antigens whenever is encountered. Antibodies are highly specific, only act on its specific antigens. If these antibodies are purified from the blood, monoclonal and polyclonal antibodies are ideal for the reagents to detect and monitor certain specific target molecules from other substances.

Neuro Immunoassay have been widely used for the pharmaceutical analysis such as diagnosis of disease, drug monitoring, pharmacokinetic and bioequivalence study of drug discovery. Immunoassay are of different format such as competitive inhibition assay, monoclonal-polyclonal sandwich assays, rapid assays and antigen-down immunoassays. The importance of neuro immunoassay in pharmaceutical industry is due to its inherent specificity, high- throughput and sensitivity for the analysis of biological samples.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-4293

Neuro Immunoassay Market: Drivers and Restraints

Neuro Immunoassay market is growing with the increasing prevalence cases of neurodegenerative diseases. The growing investments on neurobiology is expected to drive the market. The increasing geriatric population, growing technological advancement is expected to act as a driver to the global neuro immunoassay market. Increasing awareness about application of immunoassay in diagnosis and monitoring purpose of Neuro diseases. The stringent regulations by government, high cost associated with the procedure and lack of experience in using these techniques are expected to act as a restraint to the market

Neuro Immunoassay Market: Overview

Based on Technology is the major segment of the market that includes Radioimmunoassay (RIA), Polymerase Chain Reaction (PCR), ELISA, Western Blot, Rapid Tests and ELISPOT. Based on product type Reagents and Kits and Analysers. The other segment includes end users that includes hospitals, clinics, academic organizations, biopharmaceutical companies, pharmaceutical companies and others. The increasing government initiatives for the diagnosis and treatment of neuro disorders is expected to act as the driver to the overall Neuro Immunoassay market.

Neuro Immunoassay Market: Regional Overview

Region wise, the global Neuro Immunoassay market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to lead the market due to better economic condition, better government initiatives and more business investments for research and development. Latin America market is expected to hold second largest market share followed by Europe due to increasing trend towards racing competitions and awareness among population.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-4293

Market: Key Players

Some of the players in Neuro Immunoassay market includes: Intrinsic LifeSciences, Danaher Corporation (Beckman Coulter), Becton Dickinson and Company, Akers Biosciences, Inc., Abbott Laboratories, Inc, EDP Biotech Corporation, Hologic (Gen-Probe), Biomérieux and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/4293

Key Segments of the Neuro Immunoassay Market

By Technology:

Radioimmunoassays (RIA)
Polymerase Chain Reaction (PCR)
ELISA
Western Blot
Rapid Tests
ELISPOT

By Product Type:

Reagents and Kits
Analysers

By Application:

Alzheimer’s Disease
Parkinson’s Disease
Huntington’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Spinal Muscular Atrophy (SMA)

By End User:

Hospitals
Clinics
Academic Organizations
Biopharmaceutical Companies
Pharmaceutical Companies
Others

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Compression Veterinary Bandages Market is expected to accumulate US$ 113.8 Million in value by 2022-end

[287 Pages Report] By the end of 2022, the global compression veterinary bandages market is expected to be worth US$ 113.8 million. During the forecast period of 2022 to 2032, the market is expected to grow at a CAGR of 3.2%, with a closing value of US$ 160.5 million. During the 2016-2021 time period, the industry grew at a CAGR of 3.6%.

Compression Veterinary Bandages Market: Overview

The global compression veterinary bandages market is expected to show a significant growth over the forecast period. Rising horse racing craze among people is one the reason for the growth in compression veterinary bandages market. As after long day of standing and racing horse get tired, so compression veterinary bandages are used to reduce the swelling in the legs of horse by removing lymph fluid. Horses have about 8,000 lymph nodes making them more prone to the development of swelling. Increasing focus of owner on providing better care to their animals and commercialization of animal trading is also expected to drive the growth of compression veterinary bandages market as, owners want their animals to keep healthy. Companion animals segment is expected to show a better growth as people are emotionally attached to their pets leading to the higher growth in compression veterinary bandages market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5569

Veterinary bandages are necessary medical supply for pet owners and veterinary clinics or hospitals. These bandages are used to care from major and minor injuries to the animals. Compression veterinary bandage are used for the animals to prevent the bandage from falling out. These compression veterinary bandages provide effective level of compression and sustained result. The purpose of pressure or compression veterinary bandage is to control bleeding, provide support to an injured limb, minimize the swelling, protect a wound from getting contaminated and absorb fluids from a wound. Compression veterinary bandages comes in a broad range of packs and colours.

Compression Veterinary Bandages Market: Drivers and Restraints

The global compression veterinary bandages market is expected to be driven by the increasing focus of people on taming their farm animals and pets. With the advancement in the technology, companies have developed compression veterinary bandages and products that stick to itself and does not require any extra substance. Development of advanced compression veterinary bandages and better care products is also expected to fuel the growth of the market. Rise in the number of companies that are manufacturing the products for animals care is also expected to drive the growth of compression veterinary bandages market. Rising trend of horse racing is also expected to drive the market of compression veterinary bandages as this helps to remove toxins and lymph fluid along with managing swelling as horse legs can swell after a long day of standing and racing.

Compression Veterinary Bandages Market: Region Wise Outlook

The global compression veterinary bandages market can be segmented into regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Asia Pacific compression veterinary bandages market is dominating the global market as, this region has highest number of animals and animals trading is more common in the region. Asia Pacific excluding Japan is expected to continue to dominate the market of compression veterinary bandages market. Middle East and Africa region is also expected to show significant growth in compression veterinary bandages market as this region has trend of horse racing.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5569

Compression Veterinary Bandages Market: Key Players

Some of the market participants in the global compression veterinary bandages market are, EquiCrown, Merck Sharp & Dohme Corp., Millpledge Pharmaceuticals, Andover Healthcare, Inc., and America’s Acres Health & Safety Products. These companies are focusing on development of compression veterinary bandages specific for the animals such as, specialized bandages for horses.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5569

Compression Veterinary Bandages Market: Segmentation

The global compression veterinary bandages market is segmented on the basis of product type, animal type, distribution channel and region.

On the basis of product type the global compression veterinary bandages market can be segmented into:

Long Stretch or Elastic Bandages
Short Stretch or Low Elasticity Bandages
Multicomponent Multilayer Bandages

On the basis of animal type the global compression veterinary bandages market can be segmented into:

Companion Animals or Pets
Farm Animals

On the basis of distribution channel the global compression veterinary bandages market can be segmented into:

Retail Pharmacy
Online Pharmacy
Veterinary Clinics
Veterinary Hospitals

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

About FMI:

Visual Electrophysiology Testing Devices Market to reach a valuation of US$475.3 Mn by 2032

[306 Pages Report] Visual electrophysiology is the technique involved for recording numerous electrical signals from brain, optic nerve and eye in response to the visual stimuli. The electrophysiological responses are varied in different ways according to the disease progressions affecting the optic nerve, retina and visual pathways. Visual electrophysiological tests are performed with its wide range of application involving diagnosis, locating problem at some level of visual system, elimination of specific conditions, valuation of visual system maturity level in pre literate child, monitoring the progress of known condition and provision of an estimated objective measure of visual insight. The visual electrophysiology testing devices can be used for children, adults or animals of all sizes for clinical and research purpose.

The International Society for Clinical Electrophysiology of Vision (ISCEV) decides and regularly review the standards for recording all the common electrophysiological tests and are benchmarked for all visual electrophysiology services. The visual electrophysiology tests are non invasive and are performed to detect functional information about the retina and optic nerve and also allow the diagnosis of some disorders relating to retina and brain. The most common visual electrodiagnostic test is electroretinogram (ERG). The Information collected from these diagnostic tests help in establishing the correct diagnosis or is helpful to rule out related ophthalmic diseases.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5268

Visual Electrophysiology Testing Devices Market: Drivers and Restrains

Visual electrophysiology testing devices market is growing with the increasing prevalence cases of eye and neurological disorders. The growing investment on visual electrophysiology testing devices is anticipated to drive the market. The growing technological advancement, increasing geriatric population, and increased adoption practice to the visual electrophysiology diagnosis is expected to act as a driver to the global visual electrophysiology testing device market. Increasing awareness about adverse effects of the visual and neurological disorders are expected to create opportunity for the visual electrophysiology testing devices providers. The stringent regulations by government for recording electrical signals in electrophysiological test, high cost associated with the diagnosis and treatment procedure and lack of experience in using these advanced technology are expected to act as a restraint to the global visual electrophysiology testing devices market.

Visual Electrophysiology Testing Devices Market: Segmentation

The global visual electrophysiology testing devices market is classified on the basis of test type, modality, end user and geography.

Global visual electrophysiology testing device market, by Test Type:

Electroretinogram (ERG)
Multifocal Electroretinogram (mfERG)
Electro-oculogram (EOG)
Visual-evoked responses (VER)

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5268

Global visual electrophysiology testing device market, by Modality:

Fixed
Portable

Global visual electrophysiology testing device market, by End User:

Hospital
Ambulatory Surgical Centers
Clinics
Diagnostic Imaging Centers
Other

Visual Electrophysiology Testing Devices Market: Overview

Visual electrophysiology testing is performed according to the disorder. On the basis of test type, electroretinogram and visual-evoked responses are the most widely used test in the visual electrophysiology respectively. An ERG is advantageous in evaluating both hereditary (inherited) and acquired disorders of the retina. The diagnoses commonly suspects the predominant conditions of the retina including retinitis pigmentosa,retinitis pigmentosa sine pigmento,, choroideremia,, achromatopsia,and congenital stationary night blindness. The increasing government initiatives for the early diagnosis and treatment of visual and neurological disorders are expected to upsurge the overall visual electrophysiology testing device market.

Buy this report @ https://www.futuremarketinsights.com/checkout/5268

Visual Electrophysiology Testing Devices Market: Regional Overview

Geographically, the global visual electrophysiology testing devices market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America followed by Western Europe is expected to dominate global visual electrophysiology testing devices market over the forecast period due to high incidence of visual disorders. Asia Pacific and Middle Eastern Countries are anticipated to be the fastest growing regions in the field of visual electrophysiology testing devices with the improving economic conditions and health facilities. Japan holds large market share owing to the presence of technologically advanced scenario in the region.

Visual Electrophysiology Testing Devices Market: Key Players

Some of the major players identified in global visual electrophysiology testing devices market include Konan Medical USA, Inc., Diopsys, Inc, Nationwide Children’s Hospital, The Royal College of Ophthalmologists, ., LKC Technologies, Inc., Metrovision, etc. among others.

About FMI: